Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
22.80
0.00 (0.00%)
Apr 28, 2026, 6:07 PM AST

TADAWUL:9620 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Revenue
20.3819.8618.0317.01
Revenue Growth (YoY)
2.62%10.11%6.04%-
Cost of Revenue
12.5811.569.878.7
Gross Profit
7.798.298.178.31
Selling, General & Admin
5.293.64.154.68
Other Operating Expenses
----0.11
Operating Expenses
5.293.183.824.58
Operating Income
2.55.124.343.73
Interest Expense
-0.06-0.07-0.09-0.1
Other Non Operating Income (Expenses)
0.02---
Pretax Income
2.465.044.263.63
Income Tax Expense
0.490.260.10.12
Net Income
1.974.784.163.51
Net Income to Common
1.974.784.163.51
Net Income Growth
-58.84%14.85%18.47%-
Shares Outstanding (Basic)
331-
Shares Outstanding (Diluted)
331-
Shares Change (YoY)
-69.42%--
EPS (Basic)
0.791.912.82-
EPS (Diluted)
0.791.912.82-
EPS Growth
-58.84%-32.21%--
Free Cash Flow
-7.15.27-1.744.53
Free Cash Flow Per Share
-2.842.11-1.18-
Dividend Per Share
-1.500--
Gross Margin
38.24%41.76%45.29%48.87%
Operating Margin
12.28%25.77%24.09%21.95%
Profit Margin
9.65%24.07%23.08%20.66%
Free Cash Flow Margin
-34.82%26.55%-9.65%26.61%
EBITDA
3.436.055.174.63
EBITDA Margin
16.81%30.45%28.65%27.25%
D&A For EBITDA
0.920.930.820.9
EBIT
2.55.124.343.73
EBIT Margin
12.28%25.77%24.09%21.95%
Effective Tax Rate
20.05%5.24%2.27%3.32%
Advertising Expenses
0.630.430.360.17
Source: S&P Capital IQ. Standard template. Financial Sources.